Literature DB >> 30917920

Expression and purification of biologically active human granulocyte-macrophage colony stimulating factor (hGM-CSF) using silkworm-baculovirus expression vector system.

Yurie Kinoshita1, Jian Xu2, Akitsu Masuda1, Kosuke Minamihata3, Noriho Kamiya4, Hiroaki Mon1, Ryosuke Fujita5, Takahiro Kusakabe1, Jae Man Lee6.   

Abstract

Human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a hematopoietic growth factor. It is widely employed as a therapeutic agent targeting neutropenia in cancer patients undergoing chemotherapy and in patients with AIDS or after bone marrow transplantation. In this study, we constructed the recombinant baculoviruses for the expression of recombinant hGM-CSF (rhGM-CSF) with two small affinity tags (His-tag and Strep-tag) at the N or C-terminus. Compared to N-tagged rhGM-CSF, C-tagged rhGM-CSF was highly recovered from silkworm hemolymph. The purified rhGM-CSF proteins migrated as a diffuse band and were confirmed to hold N-glycosylations. A comparable activity was achieved when commercial hGM-CSF was tested as a control. Considering the high price of hGM-CSF in the market, our results and strategies using silkworm-baculovirus system can become a great reference for mass production of the active rhGM-CSF at a lower cost.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Granulocyte-macrophage colony-stimulating factor; Recombinant proteins; Silkworm-baculovirus expression system

Mesh:

Substances:

Year:  2019        PMID: 30917920     DOI: 10.1016/j.pep.2019.03.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  1 in total

1.  Semi-stable Production of Bovine IL-4 and GM-CSF in The Mammalian Episomal Expression System.

Authors:  Federico Carlos Blanco; Cristina Lourdes Vazquez; Julia Sabio Y García; Rosana Valeria Rocha; María José Gravisaco; Marina Andrea Forrellad; Giovanni Magistrelli; Fabiana Bigi
Journal:  J Vet Res       Date:  2021-08-19       Impact factor: 1.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.